3 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Cellerant Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia CLT-008, G-CSF - Acute Myeloid Leukemia, Neutropenia | Phase 2 | Completed | Cellerant Therapeutics | 163 | 2014-12-01 | 2018-09-27 |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia human myeloid progenitor cells, G-CSF - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Completed | Cellerant Therapeutics | 45 | 2011-03-01 | 2016-07-01 |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy human myeloid progenitor cells - Leukemia, Lymphoma | Phase 1 | Completed | Cellerant Therapeutics | 30 | 2009-04-01 | 2014-10-27 |
Leukemia (3) · Anemia, Refractory, with Excess of Blasts (2) · Leukemia, Myeloid, Acute (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Refractory (1) · Blast Crisis (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Fever (1) · Infections (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Chronic-Phase (1)
Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2)
United States (3)
John E Wagner, MD (1) · William Reed, MD (1)